======= CHGA ======= == Gene Information == * **Official Symbol**: CHGA * **Official Name**: chromogranin A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1113|1113]] * **UniProt**: [[https://www.uniprot.org/uniprot/P10645|P10645]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CHGA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHGA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/118910|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Pancreastatin: Strongly inhibits glucose induced insulin release from the pancreas. Serpinin: Regulates granule biogenesis in endocrine cells by up-regulating the transcription of protease nexin 1 (SERPINE2) via a cAMP-PKA-SP1 pathway. This leads to inhibition of granule protein degradation in the Golgi complex which in turn promotes granule formation. {ECO:0000250|UniProtKB:P26339}. |Granin| |adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation| |positive regulation of dense core granule biogenesis| |positive regulation of relaxation of muscle| |positive regulation of relaxation of cardiac muscle| |mast cell cytokine production| |chromaffin granule| |regulation of dense core granule biogenesis| |positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway| |protein localization to secretory granule| |adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process| |regulation of phospholipase C-activating G protein-coupled receptor signaling pathway| |mast cell chemotaxis| |mast cell migration| |myeloid leukocyte cytokine production| |regulation of relaxation of cardiac muscle| |G protein-coupled receptor signaling pathway involved in heart process| |regulation of relaxation of muscle| |positive regulation of cardiac muscle contraction| |relaxation of cardiac muscle| |positive regulation of striated muscle contraction| |negative regulation of catecholamine secretion| |mast cell degranulation| |mast cell activation involved in immune response| |mast cell mediated immunity| |relaxation of muscle| |mast cell granule| |cytokine production involved in immune response| |mast cell activation| |adenylate cyclase-activating adrenergic receptor signaling pathway| |adrenergic receptor signaling pathway| |negative regulation of amine transport| |regulation of the force of heart contraction| |positive regulation of G protein-coupled receptor signaling pathway| |defense response to fungus| |negative regulation of insulin secretion| |positive regulation of heart contraction| |negative regulation of blood vessel diameter| |transport vesicle membrane| |lysosome localization| |positive regulation of muscle contraction| |negative regulation of peptide hormone secretion| |response to fungus| |killing of cells of other organism| |disruption of cells of other organism| |regulation of catecholamine secretion| |negative regulation of hormone secretion| |positive regulation of blood circulation| |regulation of cardiac muscle contraction| |defense response to Gram-negative bacterium| |secretory granule| |cell killing| |regulation of striated muscle contraction| |defense response to Gram-positive bacterium| |regulation of amine transport| |heart process| |antimicrobial humoral response| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |myeloid leukocyte migration| |negative regulation of protein secretion| |regulation of blood vessel diameter| |negative regulation of peptide secretion| |regulation of tube diameter| |regulation of tube size| |regulation of G protein-coupled receptor signaling pathway| |leukocyte chemotaxis| |cAMP-mediated signaling| |cytokine production| |modification of morphology or physiology of other organism| |regulation of muscle contraction| |vascular process in circulatory system| |cyclic-nucleotide-mediated signaling| |regulation of insulin secretion| |production of molecular mediator of immune response| |regulation of blood pressure| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |negative regulation of secretion by cell| |negative regulation of neuron death| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |regulation of peptide hormone secretion| |cell chemotaxis| |negative regulation of secretion| |regulation of muscle system process| |regulation of heart contraction| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |regulation of hormone secretion| |regulation of blood circulation| |muscle system process| |regulation of neuron death| |defense response to bacterium| |second-messenger-mediated signaling| |humoral immune response| |establishment of organelle localization| |leukocyte migration| |blood circulation| |circulatory system process| |regulation of protein secretion| |negative regulation of transport| |regulation of peptide secretion| |leukocyte degranulation| |regulation of anatomical structure size| |myeloid leukocyte mediated immunity| |positive regulation of cellular component biogenesis| |myeloid cell activation involved in immune response| |regulation of hormone levels| |chemotaxis| |taxis| |organelle localization| |myeloid leukocyte activation| |regulation of system process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |response to bacterium| |perinuclear region of cytoplasm| |regulated exocytosis| |regulation of protein transport| |protein localization to organelle| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |leukocyte mediated immunity| |innate immune response| |exocytosis| |regulation of secretion| |interspecies interaction between organisms| |leukocyte activation| |defense response to other organism| |regulation of cellular component biogenesis| |cell migration| |negative regulation of cell death| |secretion by cell| |regulation of protein localization| |export from cell| |cell activation| |cell motility| |localization of cell| |immune effector process| |secretion| |response to other organism| |response to external biotic stimulus| |locomotion| |G protein-coupled receptor signaling pathway| |response to biotic stimulus| |defense response| |negative regulation of cell communication| |negative regulation of signaling| |intracellular transport| |movement of cell or subcellular component| |cellular protein localization| |cellular macromolecule localization| |extracellular space| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |positive regulation of multicellular organismal process| |positive regulation of cell communication| |positive regulation of signaling| |establishment of localization in cell| |regulation of transport| |immune response| |extracellular region| |vesicle-mediated transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.77| |[[:results:exp211|AICAR 240μM R05 exp211]]|-1.72| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|2.15| ^Gene^Correlation^ |[[:human genes:a:atxn1|ATXN1]]|0.425| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1971 * **Expression level (log2 read counts)**: -3.21 {{:chemogenomics:nalm6 dist.png?nolink |}}